Literature DB >> 9927709

The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance.

D J Austin1, K G Kristinsson, R M Anderson.   

Abstract

The threat to human health posed by antibiotic resistance is of growing concern. Many commensal and pathogenic organisms have developed resistance to well established and newer antibiotics. The major selection pressure driving changes in the frequency of antibiotic resistance is the volume of drug use. However, establishing a quantitative relationship between the frequency of resistance and volume of drug use has proved difficult. Using population genetic methods and epidemiological observations, we report an analysis of the influence of the selective pressure imposed by the volume of drug use on temporal changes in resistance. Analytical expressions are derived to delineate key relationships between resistance and drug consumption. The analyses indicate that the time scale for emergence of resistance under a constant selective pressure is typically much shorter than the decay time after cessation or decline in the volume of drug use and that significant reductions in resistance require equally significant reductions in drug consumption. These results highlight the need for early intervention once resistance is detected.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927709      PMCID: PMC15366          DOI: 10.1073/pnas.96.3.1152

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  The crisis in antibiotic resistance.

Authors:  H C Neu
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

Review 2.  Epidemiology of drug resistance: implications for a post-antimicrobial era.

Authors:  M L Cohen
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

3.  Antimicrobial usage and microbial resistance in a university hospital during a seven-year period.

Authors:  J K Møller
Journal:  J Antimicrob Chemother       Date:  1989-12       Impact factor: 5.790

4.  Preserving the miracle of antibiotics.

Authors:  D Greenwood
Journal:  Lancet       Date:  1995-05-27       Impact factor: 79.321

Review 5.  Antimicrobial resistance in hospital organisms and its relation to antibiotic use.

Authors:  J E McGowan
Journal:  Rev Infect Dis       Date:  1983 Nov-Dec

6.  Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States.

Authors:  J H Jorgensen; G V Doern; L A Maher; A W Howell; J S Redding
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

7.  Changes in microbial ecology and use of cloxacillin.

Authors:  J Loulergue; A Audurier; J M DeLarbre; C De Gialluly
Journal:  J Hosp Infect       Date:  1994-08       Impact factor: 3.926

8.  The antimicrobial susceptibility of Moraxella catarrhalis isolated in England and Scotland in 1991.

Authors:  C P Fung; M Powell; A Seymour; M Yuan; J D Williams
Journal:  J Antimicrob Chemother       Date:  1992-07       Impact factor: 5.790

9.  Epidemiology of plasmid-mediated beta-lactamases in enterobacteria Swedish neonatal wards and relation to antimicrobial therapy.

Authors:  L G Burman; S Haeggman; M Kuistila; K Tullus; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

10.  Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital.

Authors:  D N Gerding; T A Larson; R A Hughes; M Weiler; C Shanholtzer; L R Peterson
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

View more
  164 in total

1.  Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans.

Authors:  L E Cowen; L M Kohn; J B Anderson
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

Review 2.  Antimicrobial prescribing.

Authors:  M B Prentice
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

3.  Adherence and drug resistance: predictions for therapy outcome.

Authors:  L M Wahl; M A Nowak
Journal:  Proc Biol Sci       Date:  2000-04-22       Impact factor: 5.349

4.  The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions.

Authors:  M Lipsitch; C T Bergstrom; B R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

Review 5.  Molecular properties of bacterial multidrug transporters.

Authors:  M Putman; H W van Veen; W N Konings
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

Review 6.  Antimicrobial resistance--pharmacological solutions.

Authors:  E Rubinstein
Journal:  Infection       Date:  1999       Impact factor: 3.553

7.  Fitness cost of chromosomal drug resistance-conferring mutations.

Authors:  Peter Sander; Burkhard Springer; Therdsak Prammananan; Antje Sturmfels; Martin Kappler; Michel Pletschette; Erik C Böttger
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

8.  Biological Warfare: Implications for Antimicrobial Use.

Authors:  Ethan Rubinstein; Itzhak Levi
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

Review 9.  Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions.

Authors:  S J Schrag; B Beall; S F Dowell
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

10.  Relationship between antibiotic resistance in Streptococcus pneumoniae and that in Haemophilus influenzae: evidence for common selective pressure.

Authors:  Mark E Jones; James A Karlowsky; Renée Blosser-Middleton; Ian Critchley; Clyde Thornsberry; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.